ONO Pharmaceutical Co ( (JP:4528) ) has shared an update.
ONO Pharmaceutical Co., Ltd. reported a significant decline in its financial performance for the fiscal year ended March 31, 2025, with a notable decrease in revenue and profit compared to the previous year. Despite the downturn, the company forecasts a moderate recovery in the upcoming fiscal year, with slight revenue growth and improved profitability, indicating strategic adjustments to enhance its market position.
More about ONO Pharmaceutical Co
ONO Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily operating in the pharmaceutical industry. The company focuses on the development and sale of pharmaceutical products, with a significant emphasis on research and development to drive innovation in healthcare solutions.
Average Trading Volume: 2,748,169
Technical Sentiment Signal: Sell
Current Market Cap: Yen782.9B
Find detailed analytics on 4528 stock on TipRanks’ Stock Analysis page.